Tech Company Financing Transactions
3-V Biosciences Funding Round
3-V Biosciences, based in Menlo Park, secured investment capital from Kleiner Perkins Caufield & Byers.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3715 Haven Ave. 220
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Kemble
Chief Medical Officer
William McCulloch
Vice President
Douglas Buckley
Browse more venture capital transactions:
Prev: 6/30/2010: Transphorm venture capital transaction
Next: 6/30/2010: SpineView venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs